TY  - CONF

T1  - Cost-effectiveness analysis of nilotinib versus imatinib for the treatment of chronic phase philadelphia chromosome positive chronic myeloid leukaemia

UR  - https://eprints.whiterose.ac.uk/id/eprint/43907

PY  - 2012/06/16

AU  - Mildred M

AU  - Ward S

AU  - Squires H

AU  - Gray E

ED  - 

Y2  - 2025/11/04

ER  -